false
0001450704
0001450704
2025-10-30
2025-10-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 30, 2025
VIVAKOR, INC.
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-41286 |
|
26-2178141 |
| (State
or other jurisdiction of |
|
(Commission |
|
(IRS
Employer |
| incorporation
or organization) |
|
File
Number) |
|
Identification
No.) |
5220 Spring Valley Road, Suite 500
Dallas,
TX 75254
(Address
of principal executive offices)
(469)
480-7175
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock |
|
VIVK |
|
The
Nasdaq Stock Market LLC (Nasdaq Capital Market) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| ITEM
7.01 |
Regulation
FD Disclosure. |
On
October 30, 2025, Vivakor, Inc. (“Vivakor” or the “Company”) issued a press release announcing initiation of
a commodity trade transaction utilizing Vivakor Supply & Trading, LLC, a wholly-owned subsidiary of Vivakor. The full text of the
press release is attached to this Current Report on Form 8-K (this “Report”) as Exhibit 99.1 and is incorporated herein by
reference in this Item 7.01.
Effective
October 30, 2025, senior management and other representatives of Vivakor began using the investor presentation (the “Investor Presentation”)
included as Exhibit 99.2 to this Report in connection with presentations to existing shareholders of the Company, potential investors
of the Company, and the investment community.
Without
limiting the generality of the foregoing, the “Forward-Looking Statements” disclosure contained in the Investor Presentation
is incorporated by reference into this Item 7.01. A copy of the press release and the Investor Presentation are furnished as Exhibits
99.1 and 99.2 of this Report, respectively. The information contained in this Report, including Exhibits 99.1 and 99.2 furnished herewith,
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such
a filing.
| ITEM 9.01 |
Financial
Statements and Exhibits. |
| Exhibit
No. |
|
Title |
| 99.1 |
|
Press Release dated October 30, 2025 regarding Vivakor Supply & Trading Commodity Transaction |
| 99.2 |
|
Investor Presentation |
| 104 |
|
Cover
Page Interactive Data File (formatted as Inline XBRL). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
VIVAKOR,
INC. |
| |
|
|
| Dated: October 30,
2025 |
By: |
/s/
James H. Ballengee |
| |
|
Name: |
James
H. Ballengee |
| |
|
Title: |
Chairman, President
& CEO |